Rutgers Cancer Institute of New Jersey has appointed Michael E. Salacz, MD, as Director of its Neuro-Oncology Program. The Associate Professor of Medicine at Rutgers Robert Wood Johnson Medical School joins Rutgers Cancer Institute from the University of Kansas Medical Center, where he served as Division Chief of Neuro-Oncology and Director of the Brain and Spine Tumor Program.
Michael E. Salacz, MD
Dr. Salacz will lead the institute’s Neuro-Oncology Program, which specializes in the treatment of brain and spinal cord tumors. With more than 15 years of experience in the treatment of patients with CNS tumors, Dr. Salacz also has a background in caring for patients with metastatic tumors of the brain and spinal cord, including leptomeningeal disease.